4-(2-amino-6-chloro-9h-purin-9-yl)-1,3-dioxolane-2-methanol has been researched along with oxidopamine in 1 studies
Studies (4-(2-amino-6-chloro-9h-purin-9-yl)-1,3-dioxolane-2-methanol) | Trials (4-(2-amino-6-chloro-9h-purin-9-yl)-1,3-dioxolane-2-methanol) | Recent Studies (post-2010) (4-(2-amino-6-chloro-9h-purin-9-yl)-1,3-dioxolane-2-methanol) | Studies (oxidopamine) | Trials (oxidopamine) | Recent Studies (post-2010) (oxidopamine) |
---|---|---|---|---|---|
27 | 0 | 5 | 8,630 | 6 | 2,407 |
Protein | Taxonomy | 4-(2-amino-6-chloro-9h-purin-9-yl)-1,3-dioxolane-2-methanol (IC50) | oxidopamine (IC50) |
---|---|---|---|
Glyceraldehyde-3-phosphate dehydrogenase | Homo sapiens (human) | 8 | |
DNA repair protein RAD52 homolog | Homo sapiens (human) | 0.779 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Agari, T; Borlongan, CV; Date, I; Kondo, A; Kuramoto, S; Matsui, T; Miyoshi, Y; Shingo, T; Yasuhara, T | 1 |
1 other study(ies) available for 4-(2-amino-6-chloro-9h-purin-9-yl)-1,3-dioxolane-2-methanol and oxidopamine
Article | Year |
---|---|
Intrapallidal metabotropic glutamate receptor activation in a rat model of Parkinson's disease: behavioral and histological analyses.
Topics: Adrenergic Agents; Analysis of Variance; Animals; Behavior, Animal; Dioxolanes; Disease Models, Animal; Drug Interactions; Excitatory Amino Acid Antagonists; Female; Globus Pallidus; Methoxyhydroxyphenylglycol; Motor Activity; Oxidopamine; Parkinson Disease; Proto-Oncogene Proteins c-fos; Purines; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Substantia Nigra; Time Factors; Tyrosine 3-Monooxygenase | 2008 |